Announcements Trials
Browse Landscape

Status

Recruiting 4Unknown 2Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Spinal Cord Injuries 1

Interventions

Docetaxel 69pembrolizumab 48Prednisone 43Nivolumab 40enzalutamide 38Gemcitabine 37Sunitinib 36Cyclophosphamide 29Radiotherapy 26Magnetic Resonance Spectroscopy 26Leuprolide 25Abiraterone Acetate 25Sorafenib 23Everolimus 23Cisplatin 23bicalutamide 19atezolizumab 18Carboplatin 18Bevacizumab 18avelumab 17Radiosurgery 17Goserelin 17Interleukin-2 16abiraterone 15fludarabine 14Doxorubicin 14olaparib 13durvalumab 13cabozantinib 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Urination × Genitourinary × Clear all
NCT02538809 2025-02-13

Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Swiss Paraplegic Research, Nottwil

Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Spinal Cord Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡